Filing Details
- Accession Number:
- 0001209191-10-035772
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-25 13:00:00
- Reporting Period:
- 2010-06-24
- Filing Date:
- 2010-06-25
- Accepted Time:
- 2010-06-25 18:19:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380762 | Brian Dorsey | C/O Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130 | Svp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-06-24 | 214 | $1.23 | 214 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-24 | 214 | $4.48 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-06-24 | 354 | $1.23 | 354 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-24 | 354 | $4.48 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-06-24 | 1,412 | $1.23 | 1,412 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-24 | 1,412 | $4.48 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-06-24 | 1,833 | $1.23 | 1,833 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-24 | 1,833 | $4.48 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-06-24 | 1,392 | $1.23 | 1,392 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-24 | 1,392 | $4.48 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-06-24 | 3,795 | $1.23 | 3,795 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-24 | 3,795 | $4.48 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-06-24 | 214 | $0.00 | 214 | $1.23 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-06-24 | 354 | $0.00 | 354 | $1.23 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-06-24 | 1,412 | $0.00 | 1,412 | $1.23 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-06-24 | 1,833 | $0.00 | 1,833 | $1.23 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-06-24 | 1,392 | $0.00 | 1,392 | $1.23 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-06-24 | 3,795 | $0.00 | 3,795 | $1.23 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
849 | 2015-03-15 | No | 4 | M | Direct | |
1,410 | 2015-07-18 | No | 4 | M | Direct | |
5,645 | 2016-01-05 | No | 4 | M | Direct | |
7,334 | 2016-11-08 | No | 4 | M | Direct | |
5,556 | 2017-03-01 | No | 4 | M | Direct | |
17,039 | 2018-02-18 | No | 4 | M | Direct |
Footnotes
- This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $4.42 to $4.59 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- 1/3 of the shares of Common Stock subject to this grant vested on the date of grant (June 9, 2009) and the remaining shares will vest and become exercisable in 24 equal monthly installments over the following two year period.
- Not applicable.